MB "Enzymics" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
15,654 |
15,654 |
1,733 |
1,733 |
1,733 |
0.91 |
-0.89 |
100.00 |
11.07 |
-12,788 |
11,400 |
0 |
14,266 |
2023 |
---|
0 |
0 |
-5,189 |
-5,189 |
-3,070 |
- |
0.00 |
- |
- |
9,077 |
0 |
0 |
9,077 |
2024 |
---|
986 |
- |
-27 |
-27 |
- |
9.18 |
0.00 |
100.00 |
-2.74 |
9,050 |
0 |
0 |
9,050 |
Register and
explore Okredo data2024 |
---|
986 |
- |
-27 |
-27 |
- |
9.18 |
0.00 |
100.00 |
-2.74 |
9,050 |
0 |
0 |
9,050 |
Register and
explore Okredo data2024
Turnover (€)
986 €- *
Sales per employee (€)
-Profit before tax (€)
-27 €99 % *
Net Profit (€)
-27 €99 % *
Profit per employee (€)
-Working capital requirement
9.18 - *
Debt-to-equity ratio
0.00 - *
Total profitability (%)
100.00 %- *
Net profitability (%)
-2.74 %- *
Equity (€)
9,050 €0 % *
Amounts Payable And Liabilities (€)
0 €- *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
9,050 €0 % *